Velusetrag

Velusetrag · Alfasigma S.p.A.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Velusetrag, covering 2018-02-26 to 2025-08-03. Get the full timeline:

Most recent: Clinical Trial Update: Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO). [Phase 2]